ArticleMolecular cancer therapeutics2022
Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents.
Thapi D Rao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.